BUDA JUICE, INC. 10-K

ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Market Information Our shares of common stock are currently quoted on the NYSE American under the symbol “BUDA.” Holders As of March 26, 2026, there were approximately 12 record holders of our common stock and there were 13,066,666 shares of our common stock issued and 12,566,666 outstanding. This figure does not take into account those shareholders whose certificates are held in the name of broker-dealers or other nominees. Dividend Policy The declaration of any future cash dividends is at the discretion of our Board of Directors and depends upon our earnings, if any, our capital requirements and financial position, general economic conditions, and other pertinent conditions. We have not paid any cash dividends to the holders of our common stock, and it is not our present intention to pay any cash dividends on our common stock in the foreseeable future, but rather to reinvest earnings, if any, in our business operations. Recent Sales of Unregistered Securities The Company has not sold any securities within the past three years which were not registered under the Securities Act. Use of Proceeds from Registered Securities On January 9, 2026, we completed our initial public offering pursuant to which we issued and sold 2,666,667 shares of our common stock, including 306,667 additional shares pursuant to the exercise in full by the underwriters of their option to purchase shares of common stock from the Company), at a price to the public of $7.50 per share. The offer and sale of all of the shares of our common stock in the initial public offering (IPO) were registered under the Securities Act pursuant to our Registration Statement on Form S-1, as amended (File No. 333-289874), which were declared effective by the SEC on January 7, 2026 . Public Ventures, LLC d/b/a MDB Capital Holdings, LLC acted as the sole book-running manager for the offering. Shares of our common stock began trading on NYSE American on January 8, 2026. There has been no material change in the expected use of the net proceeds from our IPO as described in our final prospectus filed with the SEC on January 8, 2026 pursuant to Rule 424(b)(4). Purchases of Equity Securities by the Issuer and Affiliated Purchasers There were no issuer purchases of equity securities during the year ended December 31, 2025. Securities Authorized for Issuance under Equity Compensation Plans The information required by Item 5 of this Annual Report regarding equity compensation plans is incorporated herein by reference to Item 12 of Part III of this Form 10-K. ITEM 6. [RESERVED]